104 related articles for article (PubMed ID: 25762363)
1. Cost-effectiveness Analysis with Influence Diagrams.
Arias M; Díez FJ
Methods Inf Med; 2015; 54(4):353-8. PubMed ID: 25762363
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis with unordered decisions.
Díez FJ; Luque M; Arias M; Pérez-Martín J
Artif Intell Med; 2021 Jul; 117():102064. PubMed ID: 34127243
[TBL] [Abstract][Full Text] [Related]
3. Markov Influence Diagrams.
Díez FJ; Yebra M; Bermejo I; Palacios-Alonso MA; Calleja MA; Luque M; Pérez-Martín J
Med Decis Making; 2017 Feb; 37(2):183-195. PubMed ID: 28076183
[TBL] [Abstract][Full Text] [Related]
4. Use of influence diagrams to structure medical decisions.
Nease RF; Owens DK
Med Decis Making; 1997; 17(3):263-75. PubMed ID: 9219186
[TBL] [Abstract][Full Text] [Related]
5. Representation and analysis of medical decision problems with influence diagrams.
Owens DK; Shachter RD; Nease RF
Med Decis Making; 1997; 17(3):241-62. PubMed ID: 9219185
[TBL] [Abstract][Full Text] [Related]
6. The problem of embedded decision nodes in cost-effectiveness decision trees.
Arias M; Díez FJ
Pharmacoeconomics; 2014 Nov; 32(11):1141-5. PubMed ID: 25080020
[No Abstract] [Full Text] [Related]
7. Statistical cost-effectiveness analysis of two treatments based on net health benefits.
Laska EM; Meisner M; Siegel C; Wanderling J
Stat Med; 2001 Apr; 20(8):1279-302. PubMed ID: 11304742
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
9. Routine magnetic resonance imaging for idiopathic olfactory loss: a modeling-based economic evaluation.
Rudmik L; Smith KA; Soler ZM; Schlosser RJ; Smith TL
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):911-7. PubMed ID: 25211179
[TBL] [Abstract][Full Text] [Related]
10. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis.
Rudmik L; Leung R
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):802-8. PubMed ID: 25123233
[TBL] [Abstract][Full Text] [Related]
13. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
[TBL] [Abstract][Full Text] [Related]
14. An introduction to the methods of cost-effectiveness analysis.
Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
[TBL] [Abstract][Full Text] [Related]
15. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
Bala MV; Zarkin GA; Mauskopf JA
Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
[TBL] [Abstract][Full Text] [Related]
16. Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation.
Dodd PJ; Pennington JJ; Bronner Murrison L; Dowdy DW
Med Decis Making; 2018 Nov; 38(8):930-941. PubMed ID: 30403578
[TBL] [Abstract][Full Text] [Related]
17. Development of WHO guidelines on generalized cost-effectiveness analysis.
Murray CJ; Evans DB; Acharya A; Baltussen RM
Health Econ; 2000 Apr; 9(3):235-51. PubMed ID: 10790702
[TBL] [Abstract][Full Text] [Related]
18. A note on confidence intervals in cost-effectiveness analysis.
Tambour M; Zethraeus N; Johannesson M
Int J Technol Assess Health Care; 1998; 14(3):467-71. PubMed ID: 9780533
[TBL] [Abstract][Full Text] [Related]
19. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
20. Using decision analysis to assess comparative clinical efficacy of surgical treatment of unstable ankle fractures.
Michelson JD
J Orthop Trauma; 2013 Nov; 27(11):642-8. PubMed ID: 23481924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
